Isoform-level gene signature improves prognostic stratification and accurately classifies glioblastoma subtypes

por Pal, Sharmistha, Bi, Yingtao, Macyszyn, Luke, Showe, Louise C., O'Rourke, Donald M., Davuluri, Ramana V.
Publicado 2014

A dual-genotype oligoastrocytoma with histologic, molecular, radiological and time-course features

por Nasrallah, Mac Lean P., Desai, Arati, O’Rourke, Donald M., Surrey, Lea F., Stein, Joel M.
Publicado 2020

Evaluating the Association Between the Extent of Resection and Survival in Gliosarcoma

por Ahmed, Fahad I, Abdullah, Kalil G, Durgin, Joseph, Salinas, Ryan D, O'Rourke, Donald M, Brem, Steven
Publicado 2019

Clinically silent somatotroph adenomas are common

por Wade, Alisha N, Baccon, Jennifer, Grady, M Sean, Judy, Kevin D, O’Rourke, Donald M, Snyder, Peter J
Publicado 2011

Factors Associated with Increased Survival after Surgical Resection of Glioblastoma in Octogenarians

por Abdullah, Kalil G., Ramayya, Ashwin, Thawani, Jayesh P., Macyszyn, Lukasz, Martinez-Lage, Maria, O’Rourke, Donald M., Brem, Steven
Publicado 2015

Population-based MRI atlases of spatial distribution are specific to patient and tumor characteristics in glioblastoma

por Bilello, Michel, Akbari, Hamed, Da, Xiao, Pisapia, Jared M., Mohan, Suyash, Wolf, Ronald L., O’Rourke, Donald M., Martinez-Lage, Maria, Davatzikos, Christos
Publicado 2016

Rapid and ultrasensitive digital PCR (dPCR) profiling of EGFRvIII in tumor cells and tissues

por Saxena, Deeksha, Sheikh, Saad, Kao, Gary, Binder, Zev A, Alonso-Basanta, Michelle, O’Rourke, Donald M, Nasrallah, MacLean P, Dorsey, Jay F
Publicado 2019

Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-Radiotherapy

por Hu, Li, Cheng, Xingbo, Binder, Zev, Han, Zhibin, Yin, Yibo, O’Rourke, Donald M., Wang, Sida, Feng, Yumeng, Weng, Changjiang, Wu, Anhua, Lin, Zhiguo
Publicado 2021

Enhancing CAR T function with the engineered secretion of C. perfringens neuraminidase

por Durgin, Joseph S., Thokala, Radhika, Johnson, Lexus, Song, Edward, Leferovich, John, Bhoj, Vijay, Ghassemi, Saba, Milone, Michael, Binder, Zev, O'Rourke, Donald M., O'Connor, Roddy S.
Publicado 2022

PD1 Expression in EGFRvIII-Directed CAR T Cell Infusion Product for Glioblastoma Is Associated with Clinical Response

por Tang, Oliver Y., Tian, Lifeng, Yoder, Todd, Xu, Rong, Kulikovskaya, Irina, Gupta, Minnal, Melenhorst, Jan Joseph, Lacey, Simon F., O’Rourke, Donald M., Binder, Zev A.
Publicado 2022

Non-Invasive Assessment of Isocitrate Dehydrogenase-Mutant Gliomas Using Optimized Proton Magnetic Resonance Spectroscopy on a Routine Clinical 3-Tesla MRI

por de Godoy, Laiz Laura, Lim, Kheng Choon, Rajan, Archith, Verma, Gaurav, Hanaoka, Mauro, O’Rourke, Donald M., Lee, John Y. K., Desai, Arati, Chawla, Sanjeev, Mohan, Suyash
Publicado 2023

Multivariate Analysis of Preoperative Magnetic Resonance Imaging Reveals Transcriptomic Classification of de novo Glioblastoma Patients

por Rathore, Saima, Akbari, Hamed, Bakas, Spyridon, Pisapia, Jared M., Shukla, Gaurav, Rudie, Jeffrey D., Da, Xiao, Davuluri, Ramana V., Dahmane, Nadia, O'Rourke, Donald M., Davatzikos, Christos
Publicado 2019

High-Affinity Chimeric Antigen Receptor With Cross-Reactive scFv to Clinically Relevant EGFR Oncogenic Isoforms

por Thokala, Radhika, Binder, Zev A., Yin, Yibo, Zhang, Logan, Zhang, Jiasi Vicky, Zhang, Daniel Y., Milone, Michael C., Ming, Guo-li, Song, Hongjun, O’Rourke, Donald M.
Publicado 2021

PDGF-mediated mesenchymal transformation renders endothelial resistance to anti-VEGF treatment in glioblastoma

por Liu, Tianrun, Ma, Wenjuan, Xu, Haineng, Huang, Menggui, Zhang, Duo, He, Zhenqiang, Zhang, Lin, Brem, Steven, O’Rourke, Donald M., Gong, Yanqing, Mou, Yonggao, Zhang, Zhenfeng, Fan, Yi
Publicado 2018

MRI-Based Radiomics Combined with Deep Learning for Distinguishing IDH-Mutant WHO Grade 4 Astrocytomas from IDH-Wild-Type Glioblastomas

por Hosseini, Seyyed Ali, Hosseini, Elahe, Hajianfar, Ghasem, Shiri, Isaac, Servaes, Stijn, Rosa-Neto, Pedro, Godoy, Laiz, Nasrallah, MacLean P., O’Rourke, Donald M., Mohan, Suyash, Chawla, Sanjeev
Publicado 2023

Validation of multiparametric MRI based prediction model in identification of pseudoprogression in glioblastomas

por de Godoy, Laiz Laura, Mohan, Suyash, Wang, Sumei, Nasrallah, MacLean P., Sakai, Yu, O’Rourke, Donald M., Bagley, Stephen, Desai, Arati, Loevner, Laurie A., Poptani, Harish, Chawla, Sanjeev
Publicado 2023

Three‐dimensional echo planar spectroscopic imaging for differentiation of true progression from pseudoprogression in patients with glioblastoma

por Verma, Gaurav, Chawla, Sanjeev, Mohan, Suyash, Wang, Sumei, Nasrallah, MacLean, Sheriff, Sulaiman, Desai, Arati, Brem, Steven, O'Rourke, Donald M., Wolf, Ronald L., Maudsley, Andrew A., Poptani, Harish
Publicado 2018

(18)F-Fluciclovine PET to distinguish treatment-related effects from disease progression in recurrent glioblastoma: PET fusion with MRI guides neurosurgical sampling

por Henderson, Fraser, Brem, Steven, O’Rourke, Donald M, Nasrallah, MacLean, Buch, Vivek P, Young, Anthony J, Doot, Robert K, Pantel, Austin, Desai, Arati, Bagley, Stephen J, Nabavizadeh, S Ali
Publicado 2020

Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1

por Rathore, Saima, Akbari, Hamed, Rozycki, Martin, Abdullah, Kalil G., Nasrallah, MacLean P., Binder, Zev A., Davuluri, Ramana V., Lustig, Robert A., Dahmane, Nadia, Bilello, Michel, O’Rourke, Donald M., Davatzikos, Christos
Publicado 2018

The IAP antagonist birinapant enhances chimeric antigen receptor T cell therapy for glioblastoma by overcoming antigen heterogeneity

por Song, Edward Z., Wang, Xin, Philipson, Benjamin I., Zhang, Qian, Thokala, Radhika, Zhang, Logan, Assenmacher, Charles-Antoine, Binder, Zev A., Ming, Guo-li, O’Rourke, Donald M., Song, Hongjun, Milone, Michael C.
Publicado 2022